Search Results - "Sacco Simona"

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention by Sacco, Simona, Bendtsen, Lars, Ashina, Messoud, Reuter, Uwe, Terwindt, Gisela, Mitsikostas, Dimos-Dimitrios, Martelletti, Paolo

“…Background and aim Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal…”
Get full text

Gut-brain Axis and migraine headache: a comprehensive review by Arzani, Mahsa, Jahromi, Soodeh Razeghi, Ghorbani, Zeinab, Vahabizad, Fahimeh, Martelletti, Paolo, Ghaemi, Amir, Sacco, Simona, Togha, Mansoureh

“…The terminology “gut-brain axis “points out a bidirectional relationship between the GI system and the central nervous system (CNS). To date, several…”
Get full text

Incidence and 10-Year Survival of Intracerebral Hemorrhage in a Population-Based Registry by Sacco, Simona, Marini, Carmine, Toni, Danilo, Olivieri, Luigi, Carolei, Antonio

“…BACKGROUND AND PURPOSE—The purpose of this study was to evaluate the incidence and prognosis of intracerebral hemorrhage. METHODS—We analyzed data referring to…”
Get full text

The Epidemiology of Atrial Fibrillation and Stroke by Pistoia, Francesca, MD, PhD, Sacco, Simona, MD, Tiseo, Cindy, MD, Degan, Diana, MD, Ornello, Raffaele, MD, Carolei, Antonio, MD, FAHA

“…The burden of stroke is increasing due to aging population and unhealthy lifestyle habits. The considerable rise in atrial fibrillation (AF) is due to greater…”
Get full text

European headache federation consensus on the definition of resistant and refractory migraine by Sacco Simona, Braschinsky, Mark, Ducros, Anne, Lampl, Christian, Little, Patrick, van den Brink Antoinette Maassen, Pozo-Rosich, Patricia, Reuter, Uwe, de la Torre Elena Ruiz, Del Rio Margarita Sanchez, Sinclair, Alexandra J, Katsarava Zaza, Martelletti Paolo

“…IntroductionDespite advances in the management of headache disorders, some patients with migraine do not experience adequate pain relief with acute and…”
Get full text

Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy by Ornello, Raffaele, Casalena, Alfonsina, Frattale, Ilaria, Gabriele, Amleto, Affaitati, Giannapia, Giamberardino, Maria Adele, Assetta, Maurizio, Maddestra, Maurizio, Marzoli, Fabio, Viola, Stefano, Cerone, Davide, Marini, Carmine, Pistoia, Francesca, Sacco, Simona

“…Background We aimed to assess the efficacy and safety of erenumab, a fully human monoclonal antibody inhibiting the calcitonin gene-related peptide receptor…”
Get full text

Migraine and sleep disorders: a systematic review by Tiseo, Cindy, Vacca, Alessandro, Felbush, Anton, Filimonova, Tamara, Gai, Annalisa, Glazyrina, Tatyana, Hubalek, Irina Anna, Marchenko, Yelena, Overeem, Lucas Hendrik, Piroso, Serena, Tkachev, Alexander, Martelletti, Paolo, Sacco, Simona

“…Migraine and sleep disorders are common and often burdensome chronic conditions with a high prevalence in the general population, and with considerable…”
Get full text

Diagnosis and management of migraine in ten steps by Eigenbrodt, Anna K., Ashina, Håkan, Khan, Sabrina, Diener, Hans-Christoph, Mitsikostas, Dimos D., Sinclair, Alexandra J., Pozo-Rosich, Patricia, Martelletti, Paolo, Ducros, Anne, Lantéri-Minet, Michel, Braschinsky, Mark, del Rio, Margarita Sanchez, Daniel, Oved, Özge, Aynur, Mammadbayli, Ayten, Arons, Mihails, Skorobogatykh, Kirill, Romanenko, Vladimir, Terwindt, Gisela M., Paemeleire, Koen, Sacco, Simona, Reuter, Uwe, Lampl, Christian, Schytz, Henrik W., Katsarava, Zaza, Steiner, Timothy J., Ashina, Messoud

“…Migraine is a disabling primary headache disorder that directly affects more than one billion people worldwide. Despite its widespread prevalence, migraine…”
Get full text

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update by Sacco, Simona, Amin, Faisal Mohammad, Ashina, Messoud, Bendtsen, Lars, Deligianni, Christina I., Gil-Gouveia, Raquel, Katsarava, Zaza, MaassenVanDenBrink, Antoinette, Martelletti, Paolo, Mitsikostas, Dimos-Dimitrios, Ornello, Raffaele, Reuter, Uwe, Sanchez-del-Rio, Margarita, Sinclair, Alexandra J., Terwindt, Gisela, Uluduz, Derya, Versijpt, Jan, Lampl, Christian

“…Background A previous European Headache Federation (EHF) guideline addressed the use of monoclonal antibodies targeting the calcitonin gene-related peptide…”
Get full text

How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice by Tiseo, Cindy, Ornello, Raffaele, Pistoia, Francesca, Sacco, Simona

“…Background Migraine is a major public health issue associated with significant morbidity, considerable negative impact on quality of life, and significant…”
Get full text

Applying a biopsychosocial model to migraine: rationale and clinical implications by Rosignoli, Chiara, Ornello, Raffaele, Onofri, Agnese, Caponnetto, Valeria, Grazzi, Licia, Raggi, Alberto, Leonardi, Matilde, Sacco, Simona

“…Migraine is a complex condition in which genetic predisposition interacts with other biological and environmental factors determining its course. A…”
Get full text

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation by Bendtsen, Lars, Sacco, Simona, Ashina, Messoud, Mitsikostas, Dimos, Ahmed, Fayyaz, Pozo-Rosich, Patricia, Martelletti, Paolo

“…OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with…”
Get full text

Functional connectivity studies in migraine: what have we learned? by Skorobogatykh, Kirill, van Hoogstraten, Willem Sebastiaan, Degan, Diana, Prischepa, Anastasia, Savitskaya, Anastasya, Ileen, Biondo Michela, Bentivegna, Enrico, Skiba, Iaroslav, D’Acunto, Laura, Ferri, Livia, Sacco, Simona, Hansen, Jakob Møller, Amin, Faisal Mohammad

“…Background Resting-state functional connectivity (FC) MRI has widely been used to understand migraine pathophysiology and to identify an imaging marker of the…”
Get full text

CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP? by Favoni, Valentina, Giani, Luca, Al-Hassany, Linda, Asioli, Gian Maria, Butera, Calogera, de Boer, Irene, Guglielmetti, Martina, Koniari, Chrysoula, Mavridis, Theodoros, Vaikjärv, Marge, Verhagen, Iris, Verzina, Angela, Zick, Bart, Martelletti, Paolo, Sacco, Simona

“…Calcitonin gene-related peptide (CGRP) is a neuropeptide with a pivotal role in the pathophysiology of migraine. Blockade of CGRP is a new therapeutic target…”
Get full text

Early outcomes of migraine after erenumab discontinuation: data from a real-life setting by De Matteis, Eleonora, Affaitati, Giannapia, Frattale, Ilaria, Caponnetto, Valeria, Pistoia, Francesca, Giamberardino, Maria Adele, Sacco, Simona, Ornello, Raffaele

“…Background Monoclonal antibodies targeting the calcitonin gene-related peptide, including erenumab, are migraine-specific preventive treatments, whose…”
Get full text

Narrative-based medicine in headache disorders by Lampl, Christian, Sacco, Simona, Martelletti, Paolo

“…In this editorial we aim to provide an overview of Narrative-based Medicine (NBM) and highlight what it may offer to the care of individuals with headache…”
Get full text

Diabetes and Stroke: What Are the Connections? by Mosenzon, Ofri, Cheng, Alice Yy, Rabinstein, Alejandro A, Sacco, Simona

“…Stroke is a major cause of death and long-term disability worldwide. Diabetes is associated with an increased risk of cardiovascular complications, including…”
Get full text

The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal by Ornello, Raffaele, Tiseo, Cindy, Frattale, Ilaria, Perrotta, Giulia, Marini, Carmine, Pistoia, Francesca, Sacco, Simona

“…Background Erenumab, a fully human monoclonal antibody directed against the calcitonin gene-related peptide receptor, was approved for the prevention of…”
Get full text

Symptoms of gait and coordination impairment in a patient with COVID-19 interstitial pneumonia by Pistoia, Francesca, Ornello, Raffaele, Sucapane, Patrizia, Marini, Carmine, Sacco, Simona

Get full text

Association between response to triptans and response to erenumab: real-life data by Frattale, Ilaria, Caponnetto, Valeria, Casalena, Alfonsina, Assetta, Maurizio, Maddestra, Maurizio, Marzoli, Fabio, Affaitati, Giannapia, Giamberardino, Maria Adele, Viola, Stefano, Gabriele, Amleto, Pistoia, Francesca, Cerone, Davide, Marini, Carmine, Sacco, Simona, Ornello, Raffaele

“…Background Triptans and erenumab are both migraine-specific agents acting on the calcitonin gene-related peptide pathway. Therefore, response to triptans might…”
Get full text